graymatters health ltd

GMH is the first company to develop a treatment based on a digital biomarker of brain activity associated with mental health disorders. The biomarker, named EEG-fMRI-Pattern, or EFP, is based on advanced statistical models that register brain area specif

Prism uses an EEG cap that is paired with interactive audiovisuals to train patients in how to lower the biomarker associated with PTSD, thus regaining control over their brain’s emotional regulation system. By learning how to get agitated avatars to sit down in a virtual office, people with PTSD can regain control over their emotions and lower biomarkers associated with the condition.

Physicians.

Oded Kraft - CEO & President & Co-Founder